Portfolio Lab

Exponent Inc

  • Stock
  • Ticker EXPO
  • ISIN US30214U1025
  • Nasdaq

Industrials · Business services · USA

$89.16 +0.18%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Exponent Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

EXPOGlobal equities (VT)

$10,000 grew to $32,745. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −54.8% in 05/2026, measured from the peak in 12/2021. The old peak has not been reached again yet.

1-year return
+32.4%
5-year return p.a.
−5.3%
10-year return p.a.
+12.6%
Volatility p.a.
26.1%
Largest decline
−54.8%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end01/202504/202507/202510/202501/202604/202607/202610/2026
Income statement
Revenue137146142147147166172174
Operating income2744172929412842
EBITDA3047203232443145
Net income2427272825302931
Earnings per share0.450.520.520.550.490.590.600.64
Balance sheet
Total assets777763759761778687653695
Liabilities356322332359387349364387
Equity421441428403390338289308
Cash25924523220722211967115
Cash flow
Operating cash flow567.3363356-1.03163
Capital expenditure-2.6-1.8-2.3-2.7-2.7-2.5-1.8-1.2
Free cash flow535.5343053-3.42962

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2018 at +44.2%, weakest 2025 at −20.8%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
6 Nov 2026$0.64
7 Aug 2026$0.60
8 May 2026$0.59
27 Feb 2026$0.49
7 Nov 2025$0.55
8 Aug 2025$0.52
9 May 2025$0.52
28 Feb 2025$0.45
1 Nov 2024$0.50
2 Aug 2024$0.57
3 May 2024$0.59
23 Feb 2024$0.40

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€3.8bn
Market cap in trading currency
$4.24bn
Enterprise value
$4.13bn
P/E
38.4
P/S
6.43
P/B
13.77
EV/Sales
6.26
EV/EBITDA
27.4
Earnings yield
2.6%
FCF yield
3.3%

Results (last four quarters)

Revenue
$659m
Gross profit
–
EBITDA
$151m
Net income
$115m
Earnings per share
$2.32
Revenue per share
$13.86
Revenue growth
+18.1%
Earnings growth
+10.3%

Profitability

Gross margin
–
Operating margin
21.3%
Net margin
17.4%
Return on equity
32.3%
Return on assets
16.5%

Balance sheet and cash flow

Cash
$115m
Cash per share
$2.41
Financial debt
–
Debt/equity %
–
Current ratio
1.93
Book value per share
$6.47
Operating cash flow
$149m
Free cash flow
$141m

Dividend

Dividend yield
1.38%
Dividend (12 months)
$1.23
Yield (12 months)
1.38%
Payout ratio
53%
Ex-dividend date
4 Sep 2026

Shares and trading

Shares outstanding
47.6m
Volume
526,732
Avg. volume 3 months
512,838
Relative volume
1.0

Price and technicals

Price
$89.16
1 day
+0.2%
52-week high
$89.16
52-week low
$53.67
Distance to 52-week high
0.0%
Distance to 52-week low
+66.1%
Distance to 50-day line
+18.2%
Distance to 200-day line
+31.9%
RSI (14)
76
Volatility 1M
31.7%

Performance

1 week
+2.1%
1 month
+15.6%
3 months
+26.0%
6 months
+54.3%
YTD
+28.4%
1 year
+30.8%

Dates

Fiscal year end
2 Jan 2026
Most recent quarter
2 Oct 2026

Frequently asked questions

How has EXPO performed since 11/2016?

$10,000 grew to $32,745 by 20 Nov 2026, which is +12.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is EXPO?

Volatility was 26.1% per year, measured on monthly returns. The largest decline from a peak was −54.8%, with the low in 05/2026.

How does EXPO compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, EXPO returned +12.6% at 26.1%. The correlation of monthly returns was 0.29; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Exponent Inc (EXPO): Return and risk | Portfolio Lab